SEROEPIDEMIOLOGY OF HEPATITS A VIRUS INFECTION AMONG SARI THALASEMIC PATIENTS WITH CHRONIC LIVER DISEASE: IMPLICATION FOR HAV VACCINATION

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

SAFAAR M.J.; MOUSA-DOST R.; MAHDAVI M.R.; ALIASGHARIAN A.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Journal of Mazandaran University of Medical Sciences Year:2005 | Volume:15 | Issue:46 Page(s): 45-56

Download Full-Text

Persian Verion

View:

3,273

Download:

Cites:

Information Journal Paper

Title

SEROEPIDEMIOLOGY OF HEPATITS A VIRUS INFECTION AMONG SARI THALASEMIC PATIENTS WITH CHRONIC LIVER DISEASE: IMPLICATION FOR HAV VACCINATION

Author(s)

SAFAAR M.J. | MOUSA-DOST R. | MAHDAVI M.R. | ALIASGHARIAN A. | Issue Writer Certificate

Keywords

HEPATITIS AQ3

VACCINATIONQ3

CHRONIC LIVER DISEASEQ4

Abstract

Background and purpose: HEPATITIS A virus (HAV) VACCINATION has been advised for patients with CHRONIC LIVER DISEASEs as HAV super infection in these patients can result in severe or even fatal disease. In Iran the indication for HAV VACCINATION are not clear due to lack of data on HAV seroprevalence in patients with CHRONIC LIVER DISEASEs.The aim of this study was to determine the prevalence of antibodies directed against HAV in thalasemic patients with CHRONIC LIVER DISEASE, and develop a cost-effective VACCINATION strategy.Materials and methods: We reviewed medical records of 780 thalasemic patients at the Bouali-Cina Hospital Sari-Iran. Demographic and information regarding risk factors were obtained by history and questionnaire administered to all patients. Sera were collected from patients with CHRONIC LIVER DISEASE and were tested for anti-HAV antibodies. Susceptible individuals were vaccinated with HAV vaccine. The cost of VACCINATION and antibody testing were determined based on standard laboratory and clinic charges in Iran.Results: A total of 240 patients (42 patients with chronic hepatitis C, 198 with secondary hemochromatosis) were tested for anti-HAV antibodies. Of them 90.5% (217/240) were positive for anti-HAV antibody. Cost analysis revealed that prescreening for HEPATITIS A before VACCINATION at a prevalence of less than 10% was cost saving.Conclusion: The sero-prevalence of HEPATITIS A in those with CHRONIC LIVER DISEASEs was 90.5% , and was found to be similar to that of the general population in Iran. Cost analysis revealed that screening for HEPATITIS A before immunization is cost saving.

Cites

No record.

References

No record.

Cite

APA: Copy

SAFAAR, M.J., MOUSA-DOST, R., MAHDAVI, M.R., & ALIASGHARIAN, A.. (2005). SEROEPIDEMIOLOGY OF HEPATITS A VIRUS INFECTION AMONG SARI THALASEMIC PATIENTS WITH CHRONIC LIVER DISEASE: IMPLICATION FOR HAV VACCINATION. JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES, 15(46), 45-56. SID. https://sid.ir/paper/44517/en

Vancouver: Copy

SAFAAR M.J., MOUSA-DOST R., MAHDAVI M.R., ALIASGHARIAN A.. SEROEPIDEMIOLOGY OF HEPATITS A VIRUS INFECTION AMONG SARI THALASEMIC PATIENTS WITH CHRONIC LIVER DISEASE: IMPLICATION FOR HAV VACCINATION. JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES[Internet]. 2005;15(46):45-56. Available from: https://sid.ir/paper/44517/en

IEEE: Copy

M.J. SAFAAR, R. MOUSA-DOST, M.R. MAHDAVI, and A. ALIASGHARIAN, “SEROEPIDEMIOLOGY OF HEPATITS A VIRUS INFECTION AMONG SARI THALASEMIC PATIENTS WITH CHRONIC LIVER DISEASE: IMPLICATION FOR HAV VACCINATION,” JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES, vol. 15, no. 46, pp. 45–56, 2005, [Online]. Available: https://sid.ir/paper/44517/en

Related Journal Papers